Dr Reddys Laboratories (RDY) Gross Margin (2009 - 2026)

Dr Reddys Laboratories has reported Gross Margin for 18 years, with the latest figure at 46.52% in Q2 2026.

• On a quarterly basis, Gross Margin fell 1039.0% year-over-year to 46.52% in Q2 2026; TTM through Jun 2026 was 50.29%, a 739.0% decrease from a year earlier, with the FY2026 full-year figure at 52.77%, down 513.0% from the prior year.
• Gross Margin was 46.52% for Q2 2026 at Dr Reddys Laboratories, up from 44.82% in the prior quarter.
• The five-year high for Gross Margin was 60.4% in Q2 2024, with the low at 44.82% in Q1 2026.
• Average Gross Margin over 5 years is 55.73%, with a median of 57.87% recorded in 2022.
• The sharpest annual moves came in 2023 and 2026: Gross Margin soared 883 bps in 2023, then plunged 1074 bps in 2026.
• Over 5 years, Gross Margin stood at 57.24% in 2022, then gained by 2 bps to 58.5% in 2023, then increased by 0 bps to 58.68% in 2024, then fell by 9 bps to 53.63% in 2025, then slipped by 13 bps to 46.52% in 2026.
• The last three Gross Margin figures came in at 46.52% (Q2 2026), 44.82% (Q1 2026), and 53.63% (Q4 2025), per Business Quant data.